Transgene SA
Symbool: 0OCQ.L
LSE
1.248
EURMarktprijs vandaag
-3.7467
Koers/Winst Verhouding
-2.5478
Koers/Winst Groei Verhouding
135.28M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Transgene SA (0OCQ-L) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 15.7 | 26.8 | 49.6 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 22.4 | 43.7 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1.5 | 3.7 | 11.3 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0.9 | 16 | 1.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 18 | 46.5 | 62.2 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12.3 | 11.2 | 11.3 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 1.3 | 1.7 | 20.8 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 13.5 | 7 | 7.4 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 27.2 | 19.9 | 39.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 45.2 | 66.4 | 101.8 | ||||||||||||
balance-sheet.row.account-payables | 0 | 4.5 | 7 | 7.7 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1.2 | 1.2 | 1.3 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 16 | 12.3 | 15.2 | ||||||||||||
Deferred Revenue Non Current | 0 | 12.9 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 4.2 | 3.6 | 4.6 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 16.5 | 4.7 | 7.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.3 | 2.4 | ||||||||||||
balance-sheet.row.total-liab | 0 | 26.5 | 17.5 | 21.9 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 50.4 | 50.1 | 48.9 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | -105.8 | -83.4 | -50.6 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -0.2 | 0.4 | 1.5 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 71.2 | 70.8 | 67.4 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 15.6 | 37.8 | 67.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 45.2 | 66.4 | 101.8 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 15.6 | 37.8 | 67.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 1.3 | 24.1 | 64.4 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1.3 | 2.4 | 3.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | -14.4 | -2 | -2.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -22.3 | -32.8 | -19.5 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1.6 | 1.7 | 2.5 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -10 | 3.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 2.7 | 4.7 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -7.1 | 5.1 | -12.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | -3.8 | 7.1 | -14.8 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.account-payables | 0 | -2.5 | -0.8 | 2.7 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -0.8 | -1.3 | -0.7 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -7.2 | 12.4 | -10 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2.7 | -1.5 | -0.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 37.3 | 21.8 | 17.5 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 34.6 | 20.3 | 16.8 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.3 | -0.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 33.3 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 12.9 | 0.5 | -15.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 11.7 | -0.8 | 15.9 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 11.3 | -1.5 | 0.6 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 15.7 | 4.4 | 5.9 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4.4 | 5.9 | 5.3 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | -35 | -20.9 | -32.1 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -2.7 | -1.5 | -0.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -37.7 | -22.5 | -32.8 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1.2 | 3.1 | 10 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 29.6 | 32.2 | 32.9 | ||||||||||||
income-statement-row.row.gross-profit | 0 | -28.4 | -29 | -22.9 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 35 | 38.4 | 37.7 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 36.6 | 40.1 | 40.3 | ||||||||||||
income-statement-row.row.interest-income | 0 | 7.7 | 0.3 | 0.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.8 | 0.5 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 6.6 | -2.7 | 3.7 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 6.6 | -2.7 | 3.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.8 | 0.5 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1.6 | 1.7 | 2.5 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | -35.4 | -37 | -30.3 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | -28.8 | -39.6 | -26.5 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | -6.5 | -6.8 | -7 | ||||||||||||
income-statement-row.row.net-income | 0 | -22.3 | -32.8 | -19.5 |
Vaak gestelde vragen
Wat is Transgene SA (0OCQ.L) totale activa?
Transgene SA (0OCQ.L) totale activa is 45217000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is -4.763.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -6.524.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -9.816.
Wat is Transgene SA (0OCQ.L) nettowinst (netto-inkomen)?
De nettowinst is -22328000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 1257000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 34989000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.